PerkinElmer, Inc. Introduces Enhanced Protein Analysis and Imaging Portfolio

SEOUL, South Korea--(BUSINESS WIRE)--PerkinElmer, Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, dramatically strengthens its portfolio of protein analysis and imaging technologies with the introduction of five new products at the Human Proteome Organization’s (HUPO) 6th Annual World Congress in Seoul, South Korea, Oct. 6-10. The product launches are the culmination of significant research and development that focus on meeting laboratories’ demand for superior quantitative protein analysis and imaging systems, which are more precise, offer greater workflow efficiency, and have broader appeal to academic, biotech and pharmaceutical researchers.

MORE ON THIS TOPIC